Glastoz 250mg Injection
vial of 1.0 Injection.Prescription required
About this product:
| Salt Composition: | Ceftazidime (250mg) |
| Manufacturer: | Unital Pharmaceuticals Pvt Ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Glastoz 250mg Injection is an antibiotic medicine used to treat bacterial infections in your body. Glastoz 250mg Injection fights and stops the growth of many types of bacteria. This helps to improve your symptoms and cure the underlying infection. It is given as a drip (intravenous infusion) or as an injection directly into a vein or a muscle under the supervision of a healthcare professional. Your doctor will decide the correct dose for you. You should use this medicine regularly at evenly spaced intervals as per the schedule prescribed by your doctor. Do not skip any doses and finish the full course of treatment even if you feel better. Stopping the medicine too early may lead to the infection returning or worsening.
Glastoz 250mg Injection is an antibiotic. It kills the bacteria by preventing them from forming the bacterial protective covering (cell wall) which is needed for them to survive.
What organisms does Glastoz 250mg Injection cover?
Glastoz 250mg Injection is active against Pseudomonas aeruginosa, anaerobic bacteria, and Staphylococcus bacteria. It may not be effective against methicillin-resistant Staphylococcus aureus (MRSA).
How is Glastoz 250mg Injection administered?
Glastoz 250mg Injection must be administered under the supervision of a trained healthcare professional or doctor and should not be self-administered. The dosage will depend on your individual medical condition and will be decided by your healthcare provider.
Can the use of Glastoz 250mg Injection cause diarrhea?
Yes, Glastoz 250mg Injection can cause diarrhea. Glastoz 250mg Injection is an antibiotic that kills harmful bacteria. However, it can also affect the beneficial bacteria in your stomach or intestines and lead to diarrhea. If diarrhea persists, consult your doctor.
How long does Glastoz 250mg Injection take to work?
Glastoz 250mg Injection usually begins working shortly after administration. However, it may take a few days for all harmful bacteria to be eliminated and your symptoms to completely subside.
What if I do not get better after using Glastoz 250mg Injection?
If you do not feel better after completing the full course of treatment, inform your doctor. If you experience worsening symptoms while taking this medication, please contact your doctor immediately.
Is Glastoz 250mg Injection effective?
Glastoz 250mg Injection is effective when administered according to your healthcare provider's instructions. Do not discontinue taking it even if you see improvement in your condition; early discontinuation could result in symptoms returning or worsening.
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
- Do not skip any doses and finish the full course of treatment even if you feel better. Stopping it early may make the infection harder to treat.
- Diarrhea may occur as a side effect but should stop when your course is complete. Inform your doctor if it does not stop or if you find blood in your stools.
- Discontinue Glastoz 250mg Injection and inform your doctor immediately if you get a rash, itchy skin, swelling of face and mouth, or have difficulty in breathing.
- Discontinue Glastoz 250mg Injection and inform your doctor immediately if you get a rash, itchy skin, swelling of face and mouth, or have difficulty in breathing.
Alcohol
Consuming alcohol with Glastoz 250mg Injection does not cause any harmful side effects.
Breastfeed
Glastoz 250mg Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby. Avoid prolonged use of Glastoz 250mg Injection, since it may have possible effects such as rash and diarrhea.
Pregnancy
Glastoz 250mg Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.